BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18508316)

  • 1. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells.
    Huang S; He X; Ding J; Liang L; Zhao Y; Zhang Z; Yao X; Pan Z; Zhang P; Li J; Wan D; Gu J
    Int J Cancer; 2008 Aug; 123(4):972-8. PubMed ID: 18508316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
    Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
    Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
    Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H
    Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells.
    Kiyono K; Suzuki HI; Matsuyama H; Morishita Y; Komuro A; Kano MR; Sugimoto K; Miyazono K
    Cancer Res; 2009 Dec; 69(23):8844-52. PubMed ID: 19903843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling.
    Hu X; Rui W; Wu C; He S; Jiang J; Zhang X; Yang Y
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1284-91. PubMed ID: 24329763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.
    Jiang F; Mu J; Wang X; Ye X; Si L; Ning S; Li Z; Li Y
    PLoS One; 2014; 9(5):e96698. PubMed ID: 24806207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
    Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
    Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G
    Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
    Mu X; Lin S; Yang J; Chen C; Chen Y; Herzig MC; Washburn K; Halff GA; Walter CA; Sun B; Sun LZ
    PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
    Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S
    Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
    Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.
    Yan X; Wu J; Jiang Q; Cheng H; Han JJ; Chen YG
    J Mol Cell Biol; 2018 Feb; 10(1):48-59. PubMed ID: 29036306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
    Zhuo L; Liu J; Wang B; Gao M; Huang A
    Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells.
    Cao M; Seike M; Soeno C; Mizutani H; Kitamura K; Minegishi Y; Noro R; Yoshimura A; Cai L; Gemma A
    Int J Oncol; 2012 Sep; 41(3):869-75. PubMed ID: 22752005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells.
    Caja L; Sancho P; Bertran E; Fabregat I
    J Hepatol; 2011 Aug; 55(2):351-8. PubMed ID: 21147185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer.
    Brockhausen J; Tay SS; Grzelak CA; Bertolino P; Bowen DG; d'Avigdor WM; Teoh N; Pok S; Shackel N; Gamble JR; Vadas M; McCaughan GW
    Liver Int; 2015 Jan; 35(1):240-53. PubMed ID: 24576072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increase of miR-27a affects the role of cisplatin on proliferation and migration capacities of liver cancer cells.
    Li W; Yu ZX; Ma BF
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5490-5498. PubMed ID: 30229820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
    Wang B; Hsu SH; Majumder S; Kutay H; Huang W; Jacob ST; Ghoshal K
    Oncogene; 2010 Mar; 29(12):1787-97. PubMed ID: 20023698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.